Clinical Trial Update: Rivaroxaban for Antiphospholipid Antibody Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rivaroxaban for antiphospholipid antibody syndrome has completed. The update confirms the study status but does not include results in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Antibody Syndrome

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Antiphospholipid Antibody Syndrome | Phase 4 | Status: COMPLETED